LENSAR LNSRV 深 沪
等待开盘 03-26 09:30:00 美东时间
0.00
0.000
NaN.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.00
- 总市值 0
- 52周最高 0.00
- 市盈率 静 --
- 换手率 NaN.00%
- 52周最低 0.00
- 委 比 0.00%
- 总股本 0
- 历史最高 0.00
- 量 比 0
- 振 幅 NaN.00%
- 历史最低 0.00
- 每 手 1
- 风险率
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BTIG Upgrades LENSAR to Buy, Announces $10 Price Target
BTIG analyst Ryan Zimmerman upgrades LENSAR (NASDAQ:LNSR) from Neutral to Buy and announces $10 price target.
03-18 17:50
LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review
Alcon cancels $356 million LENSAR merger due to regulatory delays and FTC opposition, adding pressure on shares.
03-17 21:04
LENSAR Ends Alcon Merger, Plans Strategic Update
LENSAR ( ($LNSR) ) just unveiled an announcement. On March 16, 2026, LENSAR, In...
03-17 20:50
Biggest stock movers Tuesday: BYND, LNSR, and more
Stock futures edged lower Tuesday premarket, while oil prices ticked higher amid the ongoing Iran war. Here are some of Tuesday's biggest stock movers: Biggest stock gainers New Era Energy (NUAI) +9% ...
03-17 17:01
Lensar agrees to terminate sale to Alcon
Lensar (LNSR) reached an agreement with Alcon (ALC) to terminate its planned sale. The parties are abandoning the deal as the Federal Trade Commission is expected to block the merger agreement, accor...
03-17 04:58
LENSAR Agrees To Terminate Merger Agreement With Alcon Research
LENSAR, Inc. (NASDAQ:LNSR) ("LENSAR" or the "Company"), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, announced that it reached an agreement with Alcon
03-17 04:40
LENSAR® Announces Termination of Merger Agreement with Alcon Research, LLC
<p>LENSAR, Inc. announced the termination of its merger agreement with Alcon Research, LLC due to the Federal Trade Commission's intent to block the acquisition and the unlikelihood of obtaining U.S. regulatory approvals by the extended deadline of July 23, 2026. LENSAR will retain the $10 million deposit from Alcon. Despite the disappointment, the company remains focused on advancing its ALLY Robotic Cataract Laser System™ and driving global gro...
03-16 20:30
LENSAR files 8-K/A amendment clarifying Wells Fargo priority credit line terms for up to USD 9.2 million
LENSAR files 8-K/A amendment clarifying Wells Fargo priority credit line terms for up to USD 9.2 million LENSAR filed a Form 8-K/A amending and restating Item 8.01 of its March 12, 2026 Form 8-K to clarify terms of a Priority Credit Line Agreement with Wells Fargo. The agreement provides a revolving
03-13 18:05
LENSAR Secures $50 Million Priority Credit Line Facility
LENSAR ( ($LNSR) ) has shared an update. On March 12, 2026, LENSAR, Inc. announ...
03-13 05:04
LENSAR Provides An Update On The Status Of Its Pending Acquisition By Alcon Research; Says The Co. And Alcon Continue To Cooperate With The FTC Staff In Connection With Its Request For Additional Information And Documentary Material; Expects To Close The Transaction In The First Half Of 2026
LENSAR, Inc. (NASDAQ:LNSR) ("LENSAR" or the "Company"), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today provided an update on the status of its
02-26 06:06
